Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-19
2011-07-19
Anderson, James (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S356000, C424S273100, C260S66500B
Reexamination Certificate
active
07981916
ABSTRACT:
Metronidazole is solubilized in an aqueous phase, by mixing same with niacinamide and at least two glycolic cosolvents; the resulting solutions and pharmaceutical compositions comprised thereof are useful for the treatment of dermatological conditions/afflictions, notably rosacea.
REFERENCES:
patent: 4032645 (1977-06-01), Chien et al.
patent: 6444647 (2002-09-01), Robinson et al.
patent: 6517847 (2003-02-01), Dow et al.
patent: 2004/0242463 (2004-12-01), Kung et al.
patent: 58059913 (2003-04-01), None
patent: WO 02/06349 (2002-01-01), None
patent: WO 02/094179 (2002-11-01), None
patent: WO 03/057135 (2003-07-01), None
Chien, “Solubilization of Metronidazole by Water-Miscible Multi-Cosolvents and Water-Soluble Vitamins”, Journal of Parenteral Science and Technology, Jan. 1984, pp. 32-36, vol. 38, No. 1, Flagyl, Scarle Pharmaceuticals, Inc. IL.
International Search Report corresponding to PCT/FR 2006/001367, issued Dec. 1, 2006, 4 pages.
Brzokewicz Alain
Mallard Claire
Anderson James
Buchanan Ingersoll & Rooney P.C.
Galderma S.A.
Vakili Zohreh
LandOfFree
Solubilizing of metronidazole does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solubilizing of metronidazole, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solubilizing of metronidazole will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2656624